Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Intravenous infusions of Xyntha
DRUG
2 trials
Sponsors
Pfizer
Conditions
Hemophilia A
Phase 1
Study of PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Male Chinese Subjects With Hemophilia A
Completed
NCT02461992
Pfizer
Hemophilia A
Start: 2015-07-31
End: 2015-08-31
Updated: 2016-09-07
Phase 4
PF-05208756, Moroctocog Alfa (AF-CC), Xyntha For Hemophilia A
Completed
NCT02492984
Pfizer
Hemophilia A
Start: 2015-04-30
End: 2016-08-31
Updated: 2017-04-04
Related Papers
Safety and Efficacy of Moroctocog Alfa (AF-CC) in Chinese Patients with Hemophilia A: Results of Two Open-Label Studies.
2020-11-25
3 citations
An Open-label, Single-dose, Pharmacokinetic Study of Factor VIII Activity After Administration of Moroctocog Alfa (AF-CC) in Male Chinese Patients With Hemophilia A.
2017-06-07
2 citations